Neogen Corporation
NEOGHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeNeogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. The company carries a $2.24B market cap, placing it firmly in the mid-cap category. It operates through two segments, Food Safety and Animal Safety.
Market Cap
$2.24B
Beta
1.79
P/E (TTM)
—
P/E (Fwd)
34.23
EPS (TTM)
$-2.78
EPS (Fwd)
$0.30
ROE
-25.6%
ROA
-0.6%
Cash
$159.9M
Total Debt
$795.1M
Free CF
$19.5M
52W Change
116.7%
Annual Financials
Cash vs Debt
On the balance sheet, NEOG has $159.9M in cash with $795.1M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $19.5M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -25.6% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $527.2M (2022) to $894.7M (2025), reflecting a 70% increase over the period.
Neogen Corporation's elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Neogen Corporation's trajectory.